Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation

 

^* Both authors contributed equally and are listed in alphabetical order.

• References

• 1 Peyvandi F. Epidemiology and treatment of congenital fibrinogen deficiency. Thromb Res 2012; 130 (Suppl. 02) S7-S11.
• 2 de Moerloose P, Casini A, Neerman-Arbez M. Congenital fibrinogen disorders: an update. Semin Thromb Hemost 2013; 39: 585-595.
• 3 Teresa SM, Marta M, Emiliano DB. et al. Thrombosis of abdominal aorta in congenital abfibrinogenemia: case report and review of literature. Haemophilia 2015; 21: 88-94.
• 4 Solomon C, Gröner A, Ye J. et al. Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data. Thromb Haemost 2015; 113: 759-771.
• 5 Bornikova L, Peyvandi F, Allen G. et al. Fibrinogen replacement therapy for congenital fibrinogen deficiency. J Thromb Haemost 2011; 9: 1687-1704.
• 6 Neerman-Arbez M, de Moerloose P, Bridel C. et al. Mutations in the fibrinogenAa gene account for the majority of cases of congenital afibrinogenemia. Blood 2000; 96: 149-152.
• 7 Neerman-Arbez M, de Moerloose P, Honsberger A. et al. Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital fibrinogenemia: novel truncating mutations in the FGA and FGG genes. Hum Genet 2001; 108: 237-240.
• 8 Fellowes AP, Brennan SO, Holme R. et al. Homozygous truncation of the fibrinogen A alpha chain within the coiled coil causes congenital afibrinogenemia. Blood 2000; 96: 773-775.
• 9 Asselta R, Duga S, Spena S. et al. Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs. Blood 2001; 98: 3685-3692.
• 10 Casini A, Blondon M, Lebreton A. et al. Natural history of patients with congenital dysfibrinogenemia. Blood 2015; 125: 553-561.
• 11 Ni H, Denis CV, Subbarao S. et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000; 106: 385-392.
• 12 Dupuy E, Soria C, Molho P. et. al Embolized ischemic lesions of toes in an aETXbrinogenemic patient: possible relevance to in vivo circulating thrombin. Thromb Res 2001; 102: 211-219.